ceronapril has been researched along with Goldblatt Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, M; Kishi, K | 1 |
| DeForrest, JM; Hammerstone, S; Harvey, C; Karanewsky, D; Powell, JR; Scalese, R; Waldron, TL | 1 |
2 other study(ies) available for ceronapril and Goldblatt Syndrome
| Article | Year |
|---|---|
Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Enalapril; Hypertension, Renovascular; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR | 1993 |
Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dogs; Female; Hypertension; Hypertension, Renovascular; Lung; Macaca fascicularis; Male; Nephrectomy; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Renal Circulation; Species Specificity | 1990 |